[Literature Library] Maternal human milk oligosaccharide (HMO) secretor status, birth mode and infant microbiota development

Background
[Literature Library] Maternal human milk oligosaccharide (HMO) secretor status, birth mode and infant microbiota development
Abstract

This study found there are differences in infant gut microbiota composition depending on the secretor status of their mothers for human milk oligosaccharides (HMOs) such as 2’-fucosyllactose (2’-FL), as well as birth mode. Microbiota is compromised in caesarean-born infants of non-secretor mothers, potentially leading to increased risk of allergic diseases, and this group may benefit from corrective supplementation such as with bifidobacteria and 2’-FL.

1 min read
Reference

Korpela K, et al. Fucosylated oligosaccharides in mother’s milk alleviate the effects of caesarean birth on infant gut microbiota. Nature. 2018;8:13757.
 

WYE-EM-470-DEC-18

Hot topics